Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02624375 · ClinicalTrials.gov registry record · Phase 4
Immune Response to Shingles Vaccination
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT02624375: Completed Phase 4 study, sponsored by University of Washington.
NCT02624375 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02624375, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the immune response to varicella zoster virus (VZV).
Primary Outcome
To determine if Zostavax, when given as FDA indicated, boosts VZV-specific T-cells in the blood
Interventions
- DRUG Zoster Vaccine Live
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-11 |
| Phase | Phase 4 |
What the finished NCT02624375 record still lists
NCT02624375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Zoster Vaccine Live is the first listed.
NCT02624375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02624375 about?
NCT02624375 is a clinical study titled "Immune Response to Shingles Vaccination". The purpose of this study is to learn more about the immune response to varicella zoster virus (VZV).
What is the current status of trial NCT02624375?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2016-02. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02624375?
The interventions under investigation include: Zoster Vaccine Live (DRUG).
Who is sponsoring clinical trial NCT02624375?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02624375's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia